Table 3 Association studies of investigated genotypes in comparison of ATA- or ACA-positive SSc patients to controls in the discovery cohort

rs2736100^*

TERT

1.01 (0.84; 1.22)

0.881

1.14 (0.99; 1.31)

0.069

rs2076295^*

DSP

1.01 (0.83; 1.21)

0.945

0.94 (0.82; 1.09)

0.423

rs4727443^*

AZGP1

1.12 (0.93; 1.36)

0.226

0.96 (0.83; 1.11)

0.609

rs7934606^*

MUC2

1.00 (0.83; 1.20)

0.992

1.07 (0.93; 1.23)

0.925

rs2034650^*

IVD

0.99 (0.82; 1.19)

0.915

1.04 (0.90; 1.20)

0.584

rs1981997^*

MAPT

0.92 (0.73; 1.16)

0.495

1.15 (0.97; 1.36)

0.100

rs12610495^*

DPP9

0.98 (0.80; 1.20)

0.847

1.05 (0.90; 1.22)

0.572

rs6793295^*

LRRC34

1.15 (0.94; 1.42)

0.172

1.15 (0.98; 1.35)

0.080

rs2609255^*

FAMI3A

1.04 (0.83; 1.30)

0.736

1.00 (0.84; 1.19)

1.000

rs11191865 ^*

OBFC1

1.21 (1.00; 1.45)

0.048

0.99 (0.86; 1.14)

0.898

rs1278769^*

ATP11A

1.09 (0.89; 1.35)

0.394

0.96 (0.81; 1.14)

0.650

rs1379326^†

CSMD1

0.78 (0.46; 1.31)

0.340

0.94 (0.65; 1.36)

0.736

rs17690703

SPPL2C

0.97 (0.76; 1.26)

0.870

1.14 (0.94; 1.38)

0.184